Ana Maria Arance Fernandez

19PUBLICATIONS
210CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 24, 2026
Relatlimab plus nivolumab versus nivolumab for advanced melanoma: 5-year survival and biomarker analyses of the phase 3 RELATIVITY-047 trial.

|Aug 04, 2026
Circulating Thymidine Kinase Activity Predicts Survival and Optimal Treatment Sequencing in BRAF-Mutated Metastatic Melanoma in the SECOMBIT Trial.

|May 04, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.

|Jan 15, 2026
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma.

Reinhard Dummer, Shibing Deng, Tao Xie

|Dec 11, 2025
Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma.

Clara Martínez-Vila, Cristina Teixido, Roberto Martín

|Nov 19, 2025
Assessing brain metastasis response to immunotherapy: a pictorial review of atypical responses and intracranial adverse events.

Gary Amseian, Francisco Aya, Camilo Pineda

Pageof 4

Frequent Collaborators

9 joint publications

Paolo A Ascierto

7 joint publications

Reinhard Dummer

7 joint publications

Helen J Gogas

7 joint publications

Mario Mandalà